An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome

Figure 1

Schematic of the schedule of events for MET03 and MET04 over the progression to metabolic syndrome, SCD therapy protocol development, SCD Rx courses (defined as three 6-hour SCD treatments (A, B, and C) over a one-week period), 2-week posttherapy monitoring periods, and study termination, with respect to weeks on the atherogenic, high energy/high fat diet.